Upcoming Webinars

Alternative asset classes, like private equity, real estate, hedge funds, and private debt, are rapidly growing in popularity, particularly among investors seeking diversification, yield and overall return. Join Ryan Eisenman, Co-Founder and CEO of Arch, and Jim McMahon, Head of Wealth at STP Investments, for an insightful look at the complexities of tracking and analyzing alternative asset performance. Learn why alternative asset data remains nonstandardized, how to interpret alternative performance metrics, best practices for due diligence on alternative asset data reporting, valuation methodology within the context of your total portfolio, and how to incorporate alternatives appropriately in client portfolios.

Amazon’s managed Kubernetes services, Amazon EKS, have made it incredibly easy for organizations to get started on Kubernetes. With Amazon EKS managing the availability and scalability of nodes, it is no wonder so many users have turned to AWS for their Kubernetes Infrastructure needs. While AWS has simplified the deployment and management of Kubernetes, it can still be difficult to troubleshoot issues with all of the moving parts. During this webinar, AWS's Senior Solutions Architect, Marina Novikova, will be joining Lumigo Developer Advocate, DeveloperSteve to guide you through harnessing the power of industry-standard OpenTelemetry to dive deep into and resolve typical Kubernetes application challenges like sporadic failures, sluggish nodes, and problematic health checks. This webinar will cover: How to leverage OpenTelemetry in just 1-click, Troubleshooting common errors in Amazon EKS applications, Quickly filtering through troubleshooting data without jumping into a logging tool, And more.

This webinar will is part of the Data for Planning and Operations webinar series and will discuss shared use mobility. Shared mobility is “the shared use of a vehicle, motorcycle, scooter, bicycle, or other travel mode; it provides users with short-term access to a travel mode on an as-needed basis” (SAE International, 2018). Its scope includes micromobility services such as bikesharing and electric scooter services, as well as carsharing, micro-transit, paratransit, Transportation Network Companies (TNCs), and traditional ride-hailing (taxi) services. Shared mobility services have grown rapidly within the last few years. They help solve the “last mile” problem by providing links to and from mass transit stations and can replace car trips. They also may substitute for walking and transit trips. Some shared services can address longer trips, such as the use of micro-transit, where there is insufficient demand for efficient use of fixed route transit, or car sharing services, for occasional or periodic trips where a car is desirable.

Discover a groundbreaking webinar delving into advancements in antibody-drug conjugates (ADCs) and related patent filings. Antibody-drug conjugates are among the most promising drug classes in oncology...

In a new webinar, Manatt Health and CMMI will share an in-depth look at the MCP model, including objectives, requirements and participation options. Click to register for the free webinar.

Sacks Parente Golf, Inc. is a technology-forward golf company with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. Considering its growth opportunities in shaft technologies, in April of 2022, the Company expanded its manufacturing business to include advanced premium golf shafts by opening a new shaft manufacturing facility in St. Joseph, MO. The Company intends to manufacture and assemble substantially all products in the United States.

BFSG FWS 2023 - A Beginner's Guide to Investing (Investing 101): Learn the investing basics - Keys to investment success to help create greater financial stability in your life. - Understand the different types of investments

As we approach the end of 2023 and gear up for a fresh start in the new year, it’s crucial to set the stage for a successful 2024. On our upcoming webinar and annual planning workshop, hosts Martin and Flor will guide you through an interactive session where you will reflect on the year passed and look at what changes may need to be made for 2024 to be your best yet. During this session, we will dive deep into three key areas: Your Personal Life, Your Professional Life, and Your Business and Financial Wellbeing. Join us on November 16th at 1pm for this transformative session at the end of 2023 to prepare for a year of working smarter, not harder. This episode will qualify for 1 hour of Management and Professional Development CPD by e-Learning and will be essential viewing.

Circulating tumor DNA (ctDNA) profiling is increasingly used in solid tumor management to inform a variety of clinical research questions. ctDNA supports non-invasive testing for trial enrollment and longitudinal monitoring. It has potential applications in clinical study design, prognostication, and understanding when de-escalation may be possible.In this seminar, Valsamo Anagnostou of John Hopkins University will discuss implications in assessing ctDNA in advanced cancer given variable shed in patients, as well as considerations in selecting an approach. She will highlight data demonstrating the value of ctDNA dynamics and recently initiated clinical trials leveraging response-adaptive study designs and how this information can support clinical research to guide patient care.Mia Levy, chief medical officer at Foundation Medicine, will present clinical analysis for Foundation Medicine’s ctDNA tumor fraction method and how it can be leveraged for studies using only liquid biopsy to provide confidence in a negative result, support risk stratification, response-adaptive study designs, and dose selection. She will also highlight how the Foundation Medicine portfolio can support clinical studies leveraging ctDNA.The speakers will discuss:ctDNA-driven interventional clinical trials in immune-oncology based on molecular response.Response-adaptive study designs for targeted therapies.Early-phase clinical studies using ctDNA to support dose selection or early go/no go decisions.The clinical insights provided by Foundation Medicine’s ctDNA tumor fraction and portfolio of solutions for supporting clinical research and drug development.

Join us for an insightful conversation on the challenges and solutions of scaling health data connectivity in large organizations. Hear from industry leaders at McKesson, Takeda Pharmaceuticals, and Duke Health as they share their experiences in developing and scaling data connectivity within and across large organizations. This webinar will dive into the complexities of data-sharing strategies, scalability, compliance and privacy, enabling technologies, and what the future can hold for interconnected health data.